Richard Saynor, senior vice president and global head of classic and established products at GlaxoSmithKline PLC, is responsible for teaching old dogs new tricks; he manages aging branded products and explores innovative options for 45-year-old drugs in new markets for the pharma giant.
A portfolio containing more than 500 brands, GSK's classical and established products business covers a vast number of therapy areas...








